The global probiotics market size is expected to reach around US$ 133.92 billion by 2030 from US$ 63.11 billion in 2021 and is expected to grow at an impressive double-digit rate of 8.7% from 2022 to 2030. The rise in consumer preference towards natural products is a major factor fueling the market growth.
The study includes drivers and restraints of this market. The study provides an analysis of the global probiotics market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1564
The global probiotics market is driven by various factors such as growing penetration of internet, rising adoption of the healthy food & beverages, rising penetration of the online sales channels, and rising demand for the conveniences associated with the delivery of products. The rising disposable income, growing urban population, favorable government regulations, ease of doing business, and improved infrastructure that favors quick deliveries are the major factors that has augmented the growth of the global probiotics market. Rising growth in the food and beverage industry as a result of high consumer expenditure and favorable government policies is expected to be a major factor that is expected to boost the probiotics market growth during the forecast period.
Market Dynamics
Drivers: Health benefits associated with probiotic-fortified foods
Health awareness among consumers is on the rise, wherein utmost consumers are constantly in looking for of healthy food products for regular consumption. Probiotics has proven strong health benefits, more specifically to the human digestive system. Probiotics is found in the supplement form or as component of foods & beverages. Its integration with affordable health foods, such as yogurt, fruit authorities, and dressed dairy products has contributed to significant market size. The most generally used probiotic bacterial strains include Lactobacilli and Bifidobacteria, which are found in various dairy products, including yogurt. In the dairy category, yogurt is the most popular option for the consumption of probiotics. Manufacturers are coming up with a variety of options in the yogurt segment for instance, in 2013, Chobani, LLC (US) introduced a line of Greek yogurt in the US request, which has now come one of the leading brands across North America.
Restraints: International quality standards and regulations for probiotic products
International bodies, similar as the Canadian Food Inspection Agency, National Food Safety and Quality Service, WHO, US FDA, and European Parliament Committee on the ENVI (Environment, Public Health and Food Safety) of the EU are associated with food safety regulations. These government associations have control over the operation of multiple material and chemical during food processing, indirectly or directly. In addition, in the time 2001, the common FAO of the UN/ WHO Expert Consultation on Evaluation of health and nutritive properties of probiotics developed guidelines for assessing probiotics in food that could lead to the validation of health claims. This was to standardize the requirements needed to make health claims related to probiotic agents.
Opportunities: Probiotics can replace pharmaceutical agents
The rising demand for probiotics has revealed the customers preference towards the products with proven various health benefits. The rising evidence of health benefits associated with probiotics for health rebuilding has augmented the customer expectations towards the probiotics. This inclination toward a natural, safe, and cost-effective substitute for drugs has led to the application of probiotics as pharmaceutical agents. In addition, beneficial effects of probiotics as pharmaceutical agents appear to be dose- and strain-dependent. Clinical trials have proven that probiotics may cure certain health disorders or diseases in humans being, specifically those related to the GI tract. Therefore, the consumption of fermented dairy products comprising probiotic cultures provide various health benefits in certain clinical conditions, such as rotavirus-associated diarrhea, antibiotic-associated diarrhea, inflammatory bowel disease, Irritable Bowel Syndrome (IBS), cancer, allergenic diseases, Helicobacter pylori infection, and lactose-intolerance.
Challenges: Complexities in integrating probiotics in functional foods
The commercial and development aspects of functional food products are rather expensive, complex, and uncertain. The factors affecting the success of functional food product development are consumer demand, technological conditions, and legislative regulatory background. However, consumers’ information regarding the health benefits of specific ingredients may affect the acceptance of particular functional foods. In addition, the common functional ingredients like minerals, fiber, and vitamins, are preferred above improved and new products, like foods enriched with probiotics, prebiotics, flavonoids, conjugated linolenic acid and carotenoids.
Report Highlights
- Based on ingredient, the bacteria segment garnered the highest probiotics market share in 2020 due to surge in demand for bacteria derived probiotics food products. This is attributed to the growth in health issues that have encouraged market players to invest in R&D and launch new &innovative probiotics products.
- Based on the application, the segment named food & beverage had the major market share of the probiotics market, during the forecast period owing to the growing popularity of probiotic functional beverages& foods among consumers.
Regional Snapshot
Asia Pacific acquired a market share of over 40% and has dominated the global probiotics market in 2020. The presence of around 60% of the global population in the region has presented lucrative growth opportunities for the market players. Moreover, the rising urbanization, government investments in the infrastructural developments, growing health awareness and growth of sedentary lifestyle has prominently contributed towards the growth of the Asia Pacific probiotics market. The rising disposable income, increased popularity of probiotics among the population, improved access to the internet, growing ease in accessibility and availability of probiotics and rising penetration of the online delivery platforms like amazon and flipkart are some of the major factors that drives the market growth. Moreover, the increased adoption of the online payment platforms and the various promotional offers and discounts offered by the online payment apps like Phonepe, Paytm, Amazon Pay, and GooglePay has significantly fostered the growth of the probiotics market in this region.
Why should you invest in this report?
If you are aiming to enter the global probiotics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for probiotics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global probiotics market include:
- Yakult Honsha Co., Ltd.
- BioGaia AB
- Danone
- E. I. du Pont de Nemours and Company
- Probi AB
- Ganeden, Inc.
- Protexin
- Nestle S.A.
- Chr. Hansen Holding A/S
- Lifeway Foods, Inc.
Segments Covered in the Report
By Application
- Food & Beverages
- Dairy products
- Non-dairy beverages
- Infant formula
- Cereals
- Others (snacks, meat, bakery, and nutrition bars)
- Dietary Supplements
- Food Supplements
- Nutritional Supplements
- Specialty Supplements
- Infant Formula
- Animal Feed
By End Use
- Human
- Animal
By Distribution Channel
- Hypermarkets/Supermarkets
- Pharmacies/Drugstores
- Specialty Stores
- Online Stores
- Others
By Ingredient
- Bacteria
- Synthetic
By Function
- Regular
- Preventative Healthcare
- Therapeutic
By Form
- Dry
- Liquid
Regional Analysis:
The geographical analysis of the global probiotics market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global probiotics Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global probiotics market in 2030?
- What is the expected CAGR for the probiotics market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global probiotics market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Form Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Probiotics Market
5.1. COVID-19 Landscape: Probiotics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Probiotics Market, By Application Type
8.1. Probiotics Market, by Application Type, 2022-2030
8.1.1. Food & Beverages
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Dietary Supplements
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Animal Feed
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Probiotics Market, By End Use Type
9.1. Probiotics Market, by End Use Type, 2022-2030
9.1.1. Human
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Animal
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Probiotics Market, By Ingredient Type
10.1. Probiotics Market, by Ingredient Type, 2022-2030
10.1.1. Bacteria
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Synthetic
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Probiotics Market, By Function Type
11.1. Probiotics Market, by Function Type, 2022-2030
11.1.1. Regular
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Preventative Healthcare
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Therapeutic
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Probiotics Market, By Distribution Channel
12.1. Probiotics Market, by Distribution Channel, 2022-2030
12.1.1. Hypermarkets/Supermarkets
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Pharmacies/Drugstores
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Online Stores
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Specialty Stores
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Probiotics Market, By Form
13.1. Probiotics Market, by End Use Type, 2022-2030
13.1.1. Dry
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Liquid
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Probiotics Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.6. Market Revenue and Forecast, by Form (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Form (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.2. Market Revenue and Forecast, by End Use (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Function (2017-2030)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.11. Market Revenue and Forecast, by Form (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.6. Market Revenue and Forecast, by Form (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.9. Market Revenue and Forecast, by Function (2017-2030)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Form (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.12. Market Revenue and Forecast, by Function (2017-2030)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.14. Market Revenue and Forecast, by Form (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.15.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Form (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Application (2017-2030)
14.2.17.2. Market Revenue and Forecast, by End Use (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Function (2017-2030)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Form (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.6. Market Revenue and Forecast, by Form (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. Market Revenue and Forecast, by Form (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Form (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.12.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Form (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Application (2017-2030)
14.3.13.2. Market Revenue and Forecast, by End Use (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Function (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Form (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.6. Market Revenue and Forecast, by Form (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. Market Revenue and Forecast, by Form (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.12. Market Revenue and Forecast, by Form (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.13.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Form (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Application (2017-2030)
14.4.14.2. Market Revenue and Forecast, by End Use (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Function (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Form (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.6. Market Revenue and Forecast, by Form (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.7.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Form (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.2. Market Revenue and Forecast, by End Use (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Ingredient (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Function (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Form (2017-2030)
Chapter 15. Company Profiles
15.1. Yakult Honsha Co., Ltd.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. BioGaia AB
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Danone
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. E. I. du Pont de Nemours and Company
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Probi AB
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Ganeden, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Protexin
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Nestle S.A.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Chr. Hansen Holding A/S
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Lifeway Foods, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1564
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments